Furthermore, GS 9-10 prostate cancer with a low PSA has worse outcomes compared with cases of higher PSA, suggesting alternative molecular mechanisms leading to its increased malignancy [4,6,8]. This evidence concerns the gene KLK3 and prostate cancer.